| Study of the Composition and Bacterial Diversity of the Vaginal Microbiota in Healthy Versus Pathological Conditions (Bacterial Vaginosis) Using a Targeted Metagenomic Approach (RNA 16s) (NCT04989543) | Larena SAS | 2020-11-24 |
| EFFICACY AND SAFETY OF OVA AND LAVAGE MEDICAL DEVICES IN THE TREATMENT OF NON-SPECIFIC VULVOVAGINITIS (NCT05649735) | Ospedale del Mare | 2020-07-17 |
| Postmenopausal Pessary Users: Estrogen Versus Trimosan (NCT03943823) | The University of Texas Health Science Center, Houston | 2019-05-07 |
| Use of Blue Light Emitting Diode in the Treatment of Women With Bacterial Vaginosis: a Clinical Trial (NCT03500107) | Centro de Atenção ao Assoalho Pélvico | 2018-10-02 |
| Vaginal Ovule With Flavonoid Tea Extract for the Correction of Imbalance in the Vaginal Environment (NCT04171947) | Value Outcomes Ltd. | 2017-12-04 |
| Validity of Patient-Collected Wet Mounts (NCT02641717) | The University of Texas Health Science Center at San Antonio | 2015-11-01 |
| Diagnosing Bacterial Vaginosis/Vaginitis (BV) Using the Gynecologene Test Method (NCT02558179) | American International Biotechnology | 2015-09-01 |
| Safety and Tolerability of Metronidazole Gel 1.3% (NCT02392026) | Insud Pharma | 2015-08-12 |
| Pathogenesis of Bacterial Vaginosis in Women Who Have Sex With Women (NCT02272231) | University of Alabama at Birmingham | 2014-09-01 |
| Trial Evaluating the Safety of a Lactate Releasing Vaginal Ring for the Prophylaxis of Bacterial Vaginosis (NCT02314429) | University Ghent | 2014-09-01 |
| Safety, Tolerability and Efficacy of Vaginal Suppository WO3191 in the Post-treatment of Bacterial Vaginosis (NCT02687789) | Dr. August Wolff GmbH & Co. KG Arzneimittel | 2014-04-01 |
| Vaginal Practices in Human Immunodeficiency Virus (HIV) Positive Women in Zambia, a Bio-Behavioral Intervention "WASH-2" (NCT03134924) | University of Miami | 2013-05-03 |
| Exploratory Study to Evaluate the Effects of the Probiotics L. Rhamnosus GR-1 and L. Reuteri RC-14 (NCT02139839) | Kimberly-Clark Corporation | 2012-09-01 |
| Effect of the Etonogestrel 0.12mg/Ethinyl Estradiol 0.015mg Vaginal Ring on Vaginal Innate and Inflammatory Biomarkers (NCT01448291) | Eastern Virginia Medical School | 2011-10-01 |
| Efficacy Study of Preconception Treatment of an Asymptomatic Bacterial Infection in an Infertility Population (NCT01322971) | Stanford University | 2011-02-01 |
| Bacterial Vaginosis Screening and Treatment to Reduce Infective Complications, Abortion and Preterm Delivery (NCT00491270) | Western Galilee Hospital-Nahariya | 2011-01-01 |
| Colposeptine for the Treatment of Bacterial Vaginosis (NCT01153958) | Merck KGaA, Darmstadt, Germany | 2010-07-01 |
| A Study to Compare the Efficacy and Safety of a Combination of Ketoconazole and Clindamycin Compared to Tetracycline/Amphotericin B Combination Cream for the Treatment of Bacterial Vaginosis and Vaginal Candidiasis (P08077) (NCT01293643) | Merck Sharp & Dohme LLC | 2010-05-01 |
| Dose Ranging Study of Metronidazole Vaginal Gel in the Treatment of Bacterial Vaginosis (NCT01055106) | Graceway Pharmaceuticals, LLC | 2010-01-01 |
| Maternal Effects of Bacterial Vaginosis (BV) Treatment in Pregnancy (NCT00153517) | Centers for Disease Control and Prevention | 1999-10-01 |